Genetic polymorphism in chemokine CCL22 and susceptibility to Helicobacter pylori infection-related gastric carcinoma

Cancer

Volumn 115, Issue 11, 2009, Pages 2430-2437

  Wang, Guanghai ^a,b   Yu, Dianke ^a,b   Tan, Wen ^a,b   Zhao, Dan ^a,b   Wu, Chen ^a,b   Lin, Dongxin ^a,b  

^a CANCER HOSPITAL   (China)

^b Beijing Key Laboratory for Cancer Prevention   (China)

Author keywords

CCL22; Gastric cancer; Genetic polymorphism; Helicobacter pylori infection; Macrophage derived chemokine

Indexed keywords

ALANINE; ASPARTIC ACID; HELICOBACTER PYLORI ANTIBODY; MACROPHAGE DERIVED CHEMOKINE; PROTOZOON ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CCL22 GENE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOMOZYGOSITY; HUMAN; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER;

CASE-CONTROL STUDIES; CHEMOKINE CCL22; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; STOMACH NEOPLASMS;

EID: 66649111083     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24255     Document Type: Article

References (36)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
2. Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest. 2007;117:60-69.
3. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436-444.
4. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784-789.
5. El-Omar EM, Carrington M, Chow WH, et al. Interleukin- 1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000;404:398-402. (Pubitemid 30164342)
6. Machado JC, Pharoah P, Sousa S, et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology. 2001; 121:823-829. (Pubitemid 32959393)
7. Kato S, Onda M, Yamada S, Matsuda N, Tokunaga A, Matsukura A. Association of the interleukin-1 beta genetic polymorphism and gastric cancer risk in Japanese. J Gastroenterol. 2001;36:696-699. (Pubitemid 33040943)
8. Wu MS, Wu CY, Chen CJ, Lin MT, Shun CT, Lin JT. Interleukin-10 genotypes associated with gastric cancer in Taiwanese Chinese. Int J Cancer. 2003;104:617-623. (Pubitemid 36337262)
9. Lu W, Pan K, Zhang L, Lin D, Miao X, You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor a and risk of gastric cancer in a Chinese population. Carcinogenesis. 2005;26:631-636. (Pubitemid 41214153)
10. Zhao D, Sun T, Zhang X, et al. Role of CD14 promoter polymorphisms in Helicobacter pylori infection-related gastric carcinoma. Clin Cancer Res. 2007;13:2362-2368. (Pubitemid 46698585)
11. Godiska R, Chantry D, Raport CJ, et al. Human macrophage- derived chemokine (CCL22), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J Exp Med. 1997;185:1595-1604. (Pubitemid 27203256)
12. Shimauchi T, Imai S, Hino R, Tokura Y. Production of thymus and activation-regulated chemokine and macrophage- derived chemokine by CCR4+ adult T-cell leukemia cells. Clin Cancer Res. 2005;11:2427-2435. (Pubitemid 40490204)
13. Ishida T, Ueda R. CCR4 as a novel molecular target for immunotherapy of cancer. Cancer Sci. 2006;97:1139-1146. (Pubitemid 44430638)
14. Mantovani A, Gray PA, Van Damme J, Sozzani S. Macrophage- derived chemokine (MDC). J Leukoc Biol. 2000;68:400-404.
15. Lundgren A, Trollmo C, Edebo A, Svennerholm AM, Lundin BS. Helicobacter pylori-specific CD4+ T cells home to and accumulate in the human Helicobacter pylori-infected gastric mucosa. Infect Immun. 2005;73:5612-5619. (Pubitemid 41192996)
16. Mizukami Y, Kono K, Kawaguchi Y, et al. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer. Int J Cancer. 2008;122:2286-2293.
17. You WC, Zhang L, Gail MH, et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst. 2000;92:1607-1612.
18. Brennan P. Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it? Carcinogenesis. 2002;23:381-387.
19. Betts MJ, Russell RB. Amino acid properties and consequences of substitutions. In: Barnes MR, Gray IC, eds. Bioinformatics for Geneticists. Hoboken, NJ: John Wiley & Sons, Inc; 2003:289-316.
20. Erik JS, Olson CA, Shi ZS, Kallenbach NR. Alanine is an intrinsic r-helix stabilizing amino acid. J Am Chem Soc. 1999;121:5571-5572. (Pubitemid 29292978)
21. von Heijne G. Membrane protein structure prediction. Hydrophobicity analysis and the positive-inside rule. J Mol Biol. 1992;225:487-494.
22. Spiess M. Heads or tails-what determines the orientation of proteins in the membrane. FEBS Lett. 1995;369:76-79.
23. Goder V, Spiess M. Molecular mechanism of signal sequence orientation in the endoplasmic reticulum. EMBO J. 2003;22:3645-3653. (Pubitemid 36898341)
24. Whittington HA, Freeburn RW, Godinho SI, Egan J, Haider Y, Millar AB. Analysis of an IL-10 polymorphism in idiopathic pulmonary fibrosis. Genes Immun. 2003;4:258-264. (Pubitemid 39562124)
25. Beyer M, Schultze JL. Regulatory T cells in cancer. Blood. 2006;108:804-811. (Pubitemid 44154611)
26. Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004;10:942-949. (Pubitemid 39273735)
27. Lee I, Wang L, Wells AD, Dorf ME, Ozkaynak E, Hancock WW. Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med. 2005;201:1037-1044. (Pubitemid 40524671)
28. Vulcano M, Albanesi C, Stoppacciaro A, et al. Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur J Immunol. 2001;31:812-822. (Pubitemid 32241777)
29. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531-562. (Pubitemid 38680433)
30. Kandulski A, Wex T, Kuester D, et al. Naturally occurring regulatory T cells (CD4+, CD25high, FOXP3+) in the antrum and cardia are associated with higher H. pylori colonization and increased gene expression of TGF-beta1. Helicobacter. 2008;13:295-303.
31. Rad R, Brenner L, Bauer S, et al. CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology. 2006;131:525-537. (Pubitemid 44142446)
32. Beyer M, Kochanek M, Giese T, et al. In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma. Blood. 2006;107:3940-3949.
33. Sasada T, Kimura M, Yoshida Y, Kanai M, Takabayashi A. CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer. 2003;98:1089-1099. (Pubitemid 37022112)
34. Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, Fujii H. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res. 2003;9:4404-4408. (Pubitemid 37248397)
35. Bergman M, Del Prete G, van Kooyk Y, Appelmelk B. Helicobacter pylori phase variation, immune modulation and gastric autoimmunity. Nat Rev Microbiol. 2006;4:151-159. (Pubitemid 43158158)
36. Parkin DM, Whelan SL, Ferlay J. Cancer Incidence in Five Continents. Vol VII, 1st ed. Carbondale, Ill: World Health Organization Press; 1997.